2024

Ahmad, H., Ali, A., Ali, R., Khalil, A. T., Khan, I., Khan, M. M. and Alorini, M. (2024) Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan. Neoplasia, 51, 100989. (doi: 10.1016/j.neo.2024.100989) (PMID:38537553) (PMCID:PMC11026844)

2023

Zahir, R. et al. (2023) Association of high immunohistochemical expression of minichromosome maintenance 3 with human oral squamous cell carcinoma—a preliminary study. Diagnostics, 13(1), 61. (doi: 10.3390/diagnostics13010061) (PMID:36611359) (PMCID:PMC9818330)

2022

Ali, A. et al. (2022) Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients. American Journal of Cancer Research, 12(12), pp. 5668-5683. (PMID:36628279) (PMCID:PMC9827095)

Ulain, N., Ali, A., Khan, M., Ullah, Z., Shaheen, L., Shareef, N., Yasir, M. and Mustafa, T. (2022) Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates. PLoS ONE, 17(10), e0276064. (doi: 10.1371/journal.pone.0276064) (PMID:36228032) (PMCID:PMC9560136)

Shah, S., Khan, A., Shahzad, M., Mokhtar, J. A., Harakeh, S., Kibria, Z., Mehr, A., Bano, B., Ali, A. and Yousafzai, Y. M. (2022) Determinants of response at 2 months of treatment in a cohort of Pakistani patients with pulmonary tuberculosis. Antibiotics, 11(10), 1307. (doi: 10.3390/antibiotics11101307) (PMID:36289965) (PMCID:PMC9598398)

2021

Ahmad, N., Qayum, S., Jameel, A., Ali, A., Siraj, S., Ali, J. and Yousafzai, Y. M. (2021) Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients. Pakistan Journal of Pharmaceutical Sciences, 34(6(Sup)), pp. 2289-2295. (doi: 10.36721/PJPS.2021.34.6.SUP.2289-2295.1) (PMID:35039265)

2018

Ali, A., Ali, Z., Yousafzai, Y. M. and Oien, K. A. (2018) Cancer biomarker development from basic science to clinical practice. Journal of Postgraduate Medical Institute, 32(1), pp. 3-8.

2017

Giovannetti, E., van der Borden, C.L., Frampton, A.E., Ali, A., Firuzi, O. and Peters, G.J. (2017) Never let it go: stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology, 44, pp. 43-59. (doi: 10.1016/j.semcancer.2017.04.006) (PMID:28438662)

Caparello, C., Vasile, E., Garajova, I., Ali, A. and Giovannetti, E. (2017) Oxaliplatin in pre-treated patients: maybe not the match point? Translational Cancer Research, 6(1), S163-S167. (doi: 10.21037/tcr.2017.01.35)

Zahra, M., Shah, M., Ali, A. and Rahim, R. (2017) Effects of metformin on endocrine and metabolic parameters in patients with polycystic ovary syndrome. Hormone and Metabolic Research, 49(2), pp. 103-108. (doi: 10.1055/s-0042-119041) (PMID:27813052)

2016

Ali, A. et al. (2016) Investigating various thresholds as immunohistochemistry cutoffs for observer agreement. Applied Immunohistochemistry and Molecular Morphology, 25(9), pp. 599-608. (doi: 10.1097/PAI.0000000000000357) (PMID:27093449)

2015

Ahmad, S., Shah, M., Ahmed, J., Khan, A., Hussain, H., McVey, M. and Ali, A. (2015) Association of hypoadiponectemia with smokeless/dipping tobacco use in young men. BMC Public Health, 15(1), 1072. (doi: 10.1186/s12889-015-2409-7) (PMID:26482904) (PMCID:PMC4615338)

2014

Ali, A. et al. (2014) Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel. BMC Clinical Pathology, 14, p. 35. (doi: 10.1186/1472-6890-14-35)

2013

Ali, A. and Evans, P. (2013) Multi-resource peer assisted learning in postgraduate setting: a pilot study. Journal of the College of Physicians and Surgeons Pakistan, 23(4), pp. 251-256.

2012

Jamieson, N. B. , Morran, D. C., Morton, J. P., Ali, A., Dickson, E. J., Carter, C. R., Sansom, O. J. , Evans, T. R. J. , McKay, C. J. and Oien, K. A. (2012) MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clinical Cancer Research, 18(2), pp. 534-545. (doi: 10.1158/1078-0432.CCR-11-0679)

Articles

Ahmad, H., Ali, A., Ali, R., Khalil, A. T., Khan, I., Khan, M. M. and Alorini, M. (2024) Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan. Neoplasia, 51, 100989. (doi: 10.1016/j.neo.2024.100989) (PMID:38537553) (PMCID:PMC11026844)

Zahir, R. et al. (2023) Association of high immunohistochemical expression of minichromosome maintenance 3 with human oral squamous cell carcinoma—a preliminary study. Diagnostics, 13(1), 61. (doi: 10.3390/diagnostics13010061) (PMID:36611359) (PMCID:PMC9818330)

Ali, A. et al. (2022) Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients. American Journal of Cancer Research, 12(12), pp. 5668-5683. (PMID:36628279) (PMCID:PMC9827095)

Ulain, N., Ali, A., Khan, M., Ullah, Z., Shaheen, L., Shareef, N., Yasir, M. and Mustafa, T. (2022) Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates. PLoS ONE, 17(10), e0276064. (doi: 10.1371/journal.pone.0276064) (PMID:36228032) (PMCID:PMC9560136)

Shah, S., Khan, A., Shahzad, M., Mokhtar, J. A., Harakeh, S., Kibria, Z., Mehr, A., Bano, B., Ali, A. and Yousafzai, Y. M. (2022) Determinants of response at 2 months of treatment in a cohort of Pakistani patients with pulmonary tuberculosis. Antibiotics, 11(10), 1307. (doi: 10.3390/antibiotics11101307) (PMID:36289965) (PMCID:PMC9598398)

Ahmad, N., Qayum, S., Jameel, A., Ali, A., Siraj, S., Ali, J. and Yousafzai, Y. M. (2021) Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients. Pakistan Journal of Pharmaceutical Sciences, 34(6(Sup)), pp. 2289-2295. (doi: 10.36721/PJPS.2021.34.6.SUP.2289-2295.1) (PMID:35039265)

Ali, A., Ali, Z., Yousafzai, Y. M. and Oien, K. A. (2018) Cancer biomarker development from basic science to clinical practice. Journal of Postgraduate Medical Institute, 32(1), pp. 3-8.

Giovannetti, E., van der Borden, C.L., Frampton, A.E., Ali, A., Firuzi, O. and Peters, G.J. (2017) Never let it go: stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology, 44, pp. 43-59. (doi: 10.1016/j.semcancer.2017.04.006) (PMID:28438662)

Caparello, C., Vasile, E., Garajova, I., Ali, A. and Giovannetti, E. (2017) Oxaliplatin in pre-treated patients: maybe not the match point? Translational Cancer Research, 6(1), S163-S167. (doi: 10.21037/tcr.2017.01.35)

Zahra, M., Shah, M., Ali, A. and Rahim, R. (2017) Effects of metformin on endocrine and metabolic parameters in patients with polycystic ovary syndrome. Hormone and Metabolic Research, 49(2), pp. 103-108. (doi: 10.1055/s-0042-119041) (PMID:27813052)

Ali, A. et al. (2016) Investigating various thresholds as immunohistochemistry cutoffs for observer agreement. Applied Immunohistochemistry and Molecular Morphology, 25(9), pp. 599-608. (doi: 10.1097/PAI.0000000000000357) (PMID:27093449)

Ahmad, S., Shah, M., Ahmed, J., Khan, A., Hussain, H., McVey, M. and Ali, A. (2015) Association of hypoadiponectemia with smokeless/dipping tobacco use in young men. BMC Public Health, 15(1), 1072. (doi: 10.1186/s12889-015-2409-7) (PMID:26482904) (PMCID:PMC4615338)

Ali, A. et al. (2014) Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel. BMC Clinical Pathology, 14, p. 35. (doi: 10.1186/1472-6890-14-35)

Ali, A. and Evans, P. (2013) Multi-resource peer assisted learning in postgraduate setting: a pilot study. Journal of the College of Physicians and Surgeons Pakistan, 23(4), pp. 251-256.

Jamieson, N. B. , Morran, D. C., Morton, J. P., Ali, A., Dickson, E. J., Carter, C. R., Sansom, O. J. , Evans, T. R. J. , McKay, C. J. and Oien, K. A. (2012) MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clinical Cancer Research, 18(2), pp. 534-545. (doi: 10.1158/1078-0432.CCR-11-0679)